Thus, the loss of TRPML1 expression is strongly correlated with a short survival in glioblastoma patients, suggesting that a reduction in TRPML1 expression represents a negative prognostic factor in glioblastoma patients [195]. Here, MCOLN1 is linked to glioblastoma.